Article Text

Download PDFPDF
Highlights from the literature

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Patients’ experience and satisfaction with self-administered subcutaneous DMPA use during the first year of COVID-19

Depot medroxyprogesterone acetate (DMPA) is a progestogen injectable contraceptive method. The subcutaneous (SC) formulation offers the potential for self-administration, thereby providing increased autonomy and contraceptive access. This study comprised interviews with 22 patients who had been using intramuscular, clinician-administered DMPA prior to the start of the pandemic and who received a SC prescription in the first months of the pandemic for self-administration. The respondents felt empowered at having this option. However, they also felt that this option had been forced onto them if they wanted to continue using DMPA. The respondents also discussed logistical issues in accessing DMPA-SC. Being both an acceptable and convenient contractive option, this method should be included in the information provided by those offering contraceptive counselling, and local infrastructure should be adapted in order to be able to support its use.

Effectiveness of treatment options for tubal ectopic pregnancy

Tubal ectopic pregnancy (TEP) is a common gynaecological emergency that is seen in 1–2% of all pregnancies. This systematic review and network meta-analysis compared expectant, medical and surgical management options in those with asymptomatic, stable TEPs. Thirty-one randomised trials were included evaluating 10 different treatments. All medical and expectant treatments showed higher failure …

View Full Text


  • Contributors Sole author.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.